CSIMarket
 


Momenta Pharmaceuticals inc   (MNTA)
Other Ticker:  
 

Momenta Pharmaceuticals Inc 's Leverage Ratio

MNTA's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -8.96% Momenta Pharmaceuticals Inc improved Leverage Ratio in second quarter 2020 to 0.32, above the Momenta Pharmaceuticals Inc 's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the second quarter 2020, 58 other companies have achieved lower Leverage Ratio than Momenta Pharmaceuticals Inc in the II Quarter 2020. While Leverage Ratio total ranking has improved so far in the second quarter 2020 to 735, from total ranking in the first quarter 2020 at 738 .

Explain Leverage Ratio?
Who are MNTA Customers?
What are MNTA´s Total Liabilities?


MNTA Leverage Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Change -6.45 % -7.12 % 10.92 % 11.01 % 26.36 %
Y / Y Total Liabilities Change -5.84 % 99.21 % 16.57 % 46.76 % 82.07 %
Leverage Ratio MRQ 0.32 0.33 0.44 0.53 0.32
MNTA's Total Ranking # 735 # 738 # 0 # 948 # 988
Seq. Equity Change -7.68 % 55.19 % -11.77 % -25.99 % -8.34 %
Seq. Total Liabilities Change -8.96 % 15.35 % -27.03 % 22.87 % 92.6 %



Leverage Ratio second quarter 2020 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 59
Healthcare Sector # 331
Overall Market # 735


Leverage Ratio Statistics
High Average Low
0.53 0.23 0.04
(Jun 30 2019)   (Dec 31 2011)




Financial Statements
Momenta Pharmaceuticals Inc 's Equity $ 395 Millions Visit MNTA's Balance sheet
Momenta Pharmaceuticals Inc 's Total Liabilities $ 128 Millions Visit MNTA's Balance sheet
Source of MNTA's Sales Visit MNTA's Sales by Geography


Cumulative Momenta Pharmaceuticals Inc 's Leverage Ratio

MNTA's Leverage Ratio for the trailling 12 Months

MNTA Leverage Ratio

(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity TTM Growth -6.45 % -7.12 % 10.92 % 11.01 % 26.36 %
Y / Y Total Liabilities TTM Growth -5.84 % 99.21 % 16.57 % 46.76 % 82.07 %
Leverage Ratio TTM 0.39 0.39 0.34 0.33 0.3
Total Ranking TTM # 583 # 321 # 0 # 11 # 706
Seq. Equity TTM Growth -7.68 % 55.19 % -11.77 % -25.99 % -8.34 %
Seq. Total Liabilities TTM Growth -8.96 % 15.35 % -27.03 % 22.87 % 92.6 %


On the trailing twelve months basis Due to repayements of liabilities of -8.96% Momenta Pharmaceuticals Inc has not changed Leverage Ratio in the 12 months ending in II Quarter 2020 to 0.39, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 39, during the past 12 months, other companies have achieved lower Leverage Ratio than Momenta Pharmaceuticals Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the II Quarter 2020, compared to the prior period, from 321 to 583.

Explain Leverage Ratio?
Who are MNTA Customers?
What are MNTA´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 40
Healthcare Sector # 257
Within the Market # 583


trailing twelve months Leverage Ratio Statistics
High Average Low
0.39 0.26 0.13
(Jun 30 2020)   (Dec 31 2015)




Companies with similar Leverage Ratio in the quarter ending Jun 30 2020, within Biotechnology & Pharmaceuticals Industry Leverage RatioJun 30 2020 MRQ Total LiabilitiesJun 30 2020 MRQ Equity
Neurocrine Biosciences Inc   0.82 $ 684.400  Millions$ 831.200  Millions
Biocardia Inc  0.80 $ 5.837  Millions$ 7.291  Millions
Polarityte Inc   0.79 $ 23.490  Millions$ 29.567  Millions
Cidara Therapeutics Inc   0.78 $ 32.051  Millions$ 41.352  Millions
Sangamo Therapeutics Inc   0.75 $ 383.202  Millions$ 511.206  Millions
Eiger Biopharmaceuticals Inc   0.74 $ 43.094  Millions$ 58.491  Millions
Evaxion Biotech A  0.70 $ 4.927  Millions$ 7.038  Millions
Voyager Therapeutics Inc   0.70 $ 53.804  Millions$ 76.884  Millions
Biontech Se  0.69 $ 1,060.387  Millions$ 1,536.468  Millions
Meiragtx Holdings Plc  0.68 $ 117.846  Millions$ 172.766  Millions
Armata Pharmaceuticals Inc   0.67 $ 19.823  Millions$ 29.638  Millions
Logicbio Therapeutics Inc   0.64 $ 18.040  Millions$ 28.156  Millions
Adaptive Biotechnologies Corporation  0.61 $ 324.883  Millions$ 529.939  Millions
Alector Inc   0.61 $ 216.699  Millions$ 355.331  Millions
Ocugen Inc   0.61 $ 8.885  Millions$ 14.623  Millions
Vaxart Inc   0.60 $ 23.955  Millions$ 40.235  Millions
Allena Pharmaceuticals Inc.  0.57 $ 10.439  Millions$ 18.373  Millions
Kaleido Biosciences Inc   0.54 $ 27.703  Millions$ 51.322  Millions
Windtree Therapeutics Inc  0.54 $ 44.867  Millions$ 83.456  Millions
Editas Medicine Inc   0.54 $ 228.709  Millions$ 426.772  Millions
Cellectis S a   0.52 $ 160.625  Millions$ 308.846  Millions
Gritstone Bio Inc   0.51 $ 49.438  Millions$ 96.228  Millions
Bio techne Corp  0.47 $ 646.397  Millions$ 1,381.192  Millions
Solid Biosciences Inc   0.42 $ 17.250  Millions$ 40.713  Millions
Rubius Therapeutics Inc   0.41 $ 85.202  Millions$ 205.474  Millions
Applied Genetic Technologies Corporation  0.41 $ 29.303  Millions$ 71.016  Millions
Kodiak Sciences Inc   0.39 $ 120.171  Millions$ 309.197  Millions
Fate Therapeutics Inc   0.38 $ 179.483  Millions$ 474.111  Millions
Fresh Tracks Therapeutics Inc   0.38 $ 7.489  Millions$ 19.910  Millions
Vericel Corporation  0.36 $ 39.095  Millions$ 107.596  Millions

Date modified: 2023-03-21T22:27:41+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com